11 OCTOBER 2023
Leveraging intellectual property as bifunctional protein degraders enter clinical trials
The field of protein degraders is at an inflection point as more degraders enter the clinical space. Evaluating the patent filing activity will play a critical role in the ability to managing opportunities for licensing and partnerships.
Authors:
Drew Lowery and Sindhu Vijayakrishnan
16 AUGUST 2023
The winners and losers of RIS implementation: an IP management perspective
RIS poses a financial threat to equipment vendors whose technology will become obsolete – these firms should thus assess the strength of their intellectual property as an urgent priority to position themselves for the market ramp-up. On the other hand, RIS stands to benefit many, including telecom service providers, consumers, vendors with enabling technology and SEP owners.
Authors:
Bruce Rubinger and Katerina Smiljkovikj
02 AUGUST 2023
Who is who: key players in the global RIS patent landscape
RIS has received attention from a diverse number of players working towards creating SEP portfolios. As the technology progresses and becomes more sophisticated and with the standardisation process underway, an acceleration of patent filings in the coming years is very likely.
Authors:
Bruce Rubinger and Katerina Smiljkovikj
26 JULY 2023
Global standardisation efforts well underway for pivotal RIS technology
RIS is a cutting-edge technology that aims to bridge the gap between 5G and 6G. As ETSI and 3GPP progress in efforts towards standardisation there are key IP management lessons for those hoping to build an effective portfolio strategy in this large and complex area.
Authors:
Bruce Rubinger and Katerina Smiljkovikj
06 JANUARY 2021
How Gilead is effectively managing past intellectual property and covid-19 anti-viral clinical trials
As covid-19 vaccines are being rolled out, many entities are expanding on their past patent portfolios as R&D increases in this sphere. But what does this mean for effective IP management?
Authors:
Drew Lowery and Rochelle Hinman
16 DECEMBER 2020
How companies are leveraging existing anti-viral drug patents for covid-19 treatments
In the race for covid-19 treatment and prevention, many entities are growing their patent portfolios as R&D increases in this sphere. But what does this mean for effective IP management?
Authors:
Drew Lowery and Rochelle Hinman
02 DECEMBER 2020
The queen's gambit – integrating a diligent Japanese prior art search into your plan can be a game changer
Getting the most out of a manual prior art search can require considerable effort but a thorough job can pay substantial dividends – as evidenced by a case involving Japanese prior art.
Authors:
Bruce Rubinger and Brendan Sever
25 NOVEMBER 2020
How to deliver top-quality prior art without overstretching your budget
Prior art searches, especially those that go back 10 to 15 years, can be a tough ask for any patent professional. Global Prior Art provides a case study to illustrate how to best execute searches.
Authors:
Bruce Rubinger and Brendan Sever
11 NOVEMBER 2020
A tale of two outcomes: what SecureWave Storage case studies reveal about prior art
Two inter partes review cases involving SecureWave Storage highlight the critical importance of a thorough, comprehensive prior art search and how a patent attorney’s hand is shaped by their perception of the available prior art.
Authors:
Bruce Rubinger and Brendan Sever
28 OCTOBER 2020
Preparing an inter partes review is a team sport: case study two
Microsoft v Mimzi LLC provides a useful case study on the importance of communication between the search team and the client legal team when preparing an inter partes review.
Authors:
Bruce Rubinger and Brendan Sever
21 OCTOBER 2020
Why diligent searches are key to inter partes reviews
Valve Corporation v Ironburg Inventions Limited provides a useful case study on the importance of a thorough prior art search in inter partes reviews and why it is so crucial to get this right first time.
Authors:
Bruce Rubinger and Brendan Sever
19 FEBRUARY 2020
A case study comparison of the AI chips patent landscape
Three case studies into recent patent filing activities of Intel, IBM, Qualcomm, Cambricon, Google and Baidu reveal how innovation in the AI chip space is being driven by new technologies and competitors entering the market, the pursuit of diverse applications and varied approaches to attain higher processor speeds and lower power.
Authors:
Bruce Rubinger and Jason Hannon
12 FEBRUARY 2020
Who is leading the AI chips IP race? Best practice in IP management
AI and its diverse applications have seen significant market growth in the past decade and an accurate IP landscape analysis can provide deep insight into this crowded space. Global Prior Art Inc conducted extensive research into the companies that have announced AI chips for cloud computing and their focus, which reveals that US and Chinese firms are leading the way.
Authors:
Bruce Rubinger and Jason Hannon
